These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1617316)
1. Autoantibodies after bone marrow transplantation in children with genetic disorders: relation to chronic graft-versus-host disease. Lortan JE; Rochfort NC; el-Tumi M; Vellodi A Bone Marrow Transplant; 1992 May; 9(5):325-30. PubMed ID: 1617316 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. Kier P; Penner E; Bakos S; Kalhs P; Lechner K; Volc-Platzer B; Wesierska-Gadek J; Sauermann G; Gadner H; Emminger-Schmidmeier W Bone Marrow Transplant; 1990 Aug; 6(2):93-6. PubMed ID: 2207457 [TBL] [Abstract][Full Text] [Related]
3. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434 [TBL] [Abstract][Full Text] [Related]
4. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Ochs LA; Miller WJ; Filipovich AH; Haake RJ; McGlave PB; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ Bone Marrow Transplant; 1994 Apr; 13(4):455-60. PubMed ID: 8019471 [TBL] [Abstract][Full Text] [Related]
5. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972 [TBL] [Abstract][Full Text] [Related]
7. Factors leading to the appearance, after BMT, of cytotoxic antibodies against T, B and activated T lymphocytes: critical appraisal. Martinetti M; Conte R; Nespoli L; Capelli E; Salvaneschi L; Porta F; Prete L; Cuccia M Haematologica; 1990; 75(5):429-35. PubMed ID: 2097261 [TBL] [Abstract][Full Text] [Related]
8. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313 [TBL] [Abstract][Full Text] [Related]
9. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation. Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006 [TBL] [Abstract][Full Text] [Related]
10. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study. Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741 [TBL] [Abstract][Full Text] [Related]
11. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522 [TBL] [Abstract][Full Text] [Related]
12. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Eisner MD; August CS Bone Marrow Transplant; 1995 May; 15(5):663-8. PubMed ID: 7670393 [TBL] [Abstract][Full Text] [Related]
13. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease. Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891 [TBL] [Abstract][Full Text] [Related]
14. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major. Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896 [TBL] [Abstract][Full Text] [Related]
15. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y; Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Quaranta S; Shulman H; Ahmed A; Shoenfeld Y; Peter J; McDonald GB; Van de Water J; Coppel R; Ostlund C; Worman HJ; Rizzetto M; Tsuneyama K; Nakanuma Y; Ansari A; Locatelli F; Paganin S; Rosina F; Manns M; Gershwin ME Clin Immunol; 1999 Apr; 91(1):106-16. PubMed ID: 10219261 [TBL] [Abstract][Full Text] [Related]
17. Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host disease. Valent P; Sillaber KC; Scherrer R; Geissler K; Kier P; Kalhs P; Kundi M; Papoian R; Bettelheim P; Hinterberger W Bone Marrow Transplant; 1992 May; 9(5):331-6. PubMed ID: 1617317 [TBL] [Abstract][Full Text] [Related]
18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
19. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644 [TBL] [Abstract][Full Text] [Related]
20. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]